MATTHEW KETTMAN: Open Payments
NPI 1245218882 · WATERLOO, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 10 payments from 10 companies in 2025. Trend: 2023 $431 · 2024 $288 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 1 | $30 |
| PRISM MEDICAL | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
| Galderma Laboratories, L.P. | 1 | $15 |
| ABBVIE INC. | 1 | $13 |
Products named: DAXXIFY, CAPLYTA, Wegovy, Veozah, NURTEC ODT, KISUNLA, JOURNAVX, QULIPTA.
Industry payments across IA — which companies pay providers there.
